GSE174749
GeoMx Cancer Transcriptome Atlas (CTA) mRNA assay on 191 ROIs from a NSCLC tumor. [NSCLC_191_grid]
Dense spatial gene expression profiling of a NSCLC tumor. This study was part of Danaher & Kim et al., "Advances in mixed cell deconvolution enable quantification of cell types in spatially resolved gene expression data" Overall design: One NSCLC tumor was profiled with the GeoMx Cancer Transcriptome Altas RNA assay. 191 ROIs were chosen, and tumor (PanCK+) and microenvironment (PanCK-) AOIs were collected from each ROI.